BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17916066)

  • 1. Validation of spermidine synthase as a drug target in African trypanosomes.
    Taylor MC; Kaur H; Blessington B; Kelly JM; Wilkinson SR
    Biochem J; 2008 Jan; 409(2):563-9. PubMed ID: 17916066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis.
    Xiao Y; McCloskey DE; Phillips MA
    Eukaryot Cell; 2009 May; 8(5):747-55. PubMed ID: 19304951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei.
    Fairlamb AH; Henderson GB; Bacchi CJ; Cerami A
    Mol Biochem Parasitol; 1987 Jun; 24(2):185-91. PubMed ID: 3114634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.
    Byers TL; Bush TL; McCann PP; Bitonti AJ
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):527-33. PubMed ID: 1672500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei.
    Bacchi CJ; Garofalo J; Mockenhaupt D; McCann PP; Diekema KA; Pegg AE; Nathan HC; Mullaney EA; Chunosoff L; Sjoerdsma A; Hutner SH
    Mol Biochem Parasitol; 1983 Mar; 7(3):209-25. PubMed ID: 6193423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
    Breton JC; Bouteille B; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
    Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric activation of trypanosomatid deoxyhypusine synthase by a catalytically dead paralog.
    Nguyen S; Jones DC; Wyllie S; Fairlamb AH; Phillips MA
    J Biol Chem; 2013 May; 288(21):15256-67. PubMed ID: 23525104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and function of polyamines in African trypanosomes.
    Willert E; Phillips MA
    Trends Parasitol; 2012 Feb; 28(2):66-72. PubMed ID: 22192816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
    Bacchi CJ; Brun R; Croft SL; Alicea K; Bühler Y
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1448-53. PubMed ID: 8726018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture.
    Nishimura K; Yanase T; Araki N; Ohnishi Y; Kozaki S; Shima K; Asakura M; Samosomsuk W; Yamasaki S
    J Parasitol; 2006 Apr; 92(2):211-7. PubMed ID: 16729674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spermidine is essential for normal proliferation of trypanosomatid protozoa.
    González NS; Huber A; Algranati ID
    FEBS Lett; 2001 Nov; 508(3):323-6. PubMed ID: 11728444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of spermidine synthase from Trypanosoma brucei brucei.
    Bitonti AJ; Kelly SE; McCann PP
    Mol Biochem Parasitol; 1984 Sep; 13(1):21-8. PubMed ID: 6513985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamine metabolism: a potential therapeutic target in trypanosomes.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel suicide inhibitor strategy for antiparasitic drug development.
    Wang CC
    J Cell Biochem; 1991 Jan; 45(1):49-53. PubMed ID: 2005184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological activation of the mitochondrion and the transformation capacity of DFMO induced intermediate and short stumpy bloodstream form trypanosomes.
    Giffin BF; McCann PP
    Am J Trop Med Hyg; 1989 May; 40(5):487-93. PubMed ID: 2499202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.